News Website

Professor Eva Dimitriadis leads breakthrough discovery into cause of unexplained infertility - Neos Kosmos

Professor Eva Dimitriadis leads breakthrough discovery into cause of unexplained infertility Neos Kosmos

Published: Oct. 23, 2024, 11 p.m.

Read Full Article

Prolonged Treatment for Endometriosis May Harm Live Birth Rate in IVF - Medpage Today

Prolonged Treatment for Endometriosis May Harm Live Birth Rate in IVF Medpage Today

Published: Oct. 23, 2024, 10:19 p.m.

Read Full Article

Endometriosis Patient to Host EMO Music Fundraiser in Columbus, Ohio, to Benefit EndoFound - Endometriosis Foundation of America - The Blossom

Endometriosis Patient to Host EMO Music Fundraiser in Columbus, Ohio, to Benefit EndoFound Endometriosis Foundation of America - The Blossom

Published: Oct. 23, 2024, 8:39 p.m.

Read Full Article

Addressing adenomyosis - Sunbury Macedon Ranges Star Weekly

Addressing adenomyosis Sunbury Macedon Ranges Star Weekly

Published: Oct. 23, 2024, 4:29 p.m.

Read Full Article

Women with endometriosis have higher odds of postpartum hemorrhage: Study - Medical Dialogues

Women with endometriosis have higher odds of postpartum hemorrhage: Study Medical Dialogues

Published: Oct. 23, 2024, 2:30 p.m.

Read Full Article

Pride of Britain's young finalists whose lives were forever changed by King Charles - MSN

Pride of Britain's young finalists whose lives were forever changed by King Charles MSN

Published: Oct. 23, 2024, 1:39 p.m.

Read Full Article

Cardiometabolic Index Predicts Endometriosis Risk - Endocrinology Advisor

Cardiometabolic Index Predicts Endometriosis Risk Endocrinology Advisor

Published: Oct. 23, 2024, 1:29 p.m.

Read Full Article

Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - The Manila Times

Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium The Manila Times

Published: Oct. 23, 2024, 10:06 a.m.

Read Full Article

Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis - Nature.com

Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis Nature.com

Published: Oct. 23, 2024, 4:55 a.m.

Read Full Article

Experiences of pain communication in endometriosis: A meta-synthesis.

Endometriosis is the leading cause of chronic pelvic pain among women. The pain associated with endometriosis significantly impacts various aspects of patients' quality of life. A notable void in the …

Published: Oct. 23, 2024, midnight

Read Full Article

communication endometriosis healthcare professionals pain patient

Latest Articles

Professor Eva Dimitriadis leads breakthrough discovery into cause of unexplained infertility - Neos Kosmos

Prolonged Treatment for Endometriosis May Harm Live Birth Rate in IVF - Medpage Today

Endometriosis Patient to Host EMO Music Fundraiser in Columbus, Ohio, to Benefit EndoFound - Endometriosis Foundation of America - The Blossom

Addressing adenomyosis - Sunbury Macedon Ranges Star Weekly

Women with endometriosis have higher odds of postpartum hemorrhage: Study - Medical Dialogues

Pride of Britain's young finalists whose lives were forever changed by King Charles - MSN

Cardiometabolic Index Predicts Endometriosis Risk - Endocrinology Advisor

Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - The Manila Times

Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis - Nature.com

Experiences of pain communication in endometriosis: A meta-synthesis.

Subscribe to Our Newsletter